Showing results (101-110 of 153) with videos related to
Sort By:
Pageof 16
Nature Communications|September 16, 2023
Discovery and pharmacophoric characterization of chemokine network inhibitors using phage-display, saturation mutagenesis and computational modellingSerena Vales, Jhanna Kryukova, Soumyanetra Chandra, et al.Journal of Clinical Immunology|February 10, 2015
Variable phenotype of severe immunodeficiencies associated with RMRP gene mutationsWinnie Ip, H Bobby Gaspar, Robert Kleta, et al.BMC Geriatrics|November 11, 2022
Implementation of a medicine management plan (MMP) to reduce medication-related harm (MRH) in older people post-hospital discharge: a randomised controlled trialKhalid Ali, Ekow A Mensah, Eugene Ace McDermott, et al.The Journal of Pediatrics|December 8, 2004
Hematopoietic stem cell transplantation for complete IFN-gamma receptor 1 deficiency: a multi-institutional surveyJoachim Roesler, Mitchell E Horwitz, Capucine Picard, et al.European Journal of Immunology|February 26, 2019
Interferon signature in patients with STAT1 gain-of-function mutation is epigenetically determinedEpp Kaleviste, Mario Saare, Timothy Ronan Leahy, et al.Lancet (London, England)|February 25, 2003
Long-term survival and transplantation of haemopoietic stem cells for immunodeficiencies: report of the European experience 1968-99Corinne Antoine, Susanna Müller, Andrew Cant, et al.Science Translational Medicine|August 26, 2011
Hematopoietic stem cell gene therapy for adenosine deaminase-deficient severe combined immunodeficiency leads to long-term immunological recovery and metabolic correctionH Bobby Gaspar, Samantha Cooray, Kimberly C Gilmour, et al.The New England Journal of Medicine|April 19, 2002
Sustained correction of X-linked severe combined immunodeficiency by ex vivo gene therapySalima Hacein-Bey-Abina, Françoise Le Deist, Frédérique Carlier, et al.Clinical Immunology (Orlando, Fla.)|May 1, 2020
ADA2 deficiency complicated by EBV-driven lymphoproliferative diseaseEmily Staples, Ilenia Simeoni, Jonathan C Stephens, et al.Biomaterials|June 22, 2005
Assessing the in vitro biocompatibility of a novel carbon device for the treatment of sepsisSusan R Sandeman, Carol A Howell, Gary J Phillips, et al.Pageof 16